Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial

Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T08:00:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    - Version updated from v3.4.1 to v3.4.2. No user-facing content or functionality changes observed.
    Difference
    0.0%
    Check dated 2026-02-13T17:55:41.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Updated site revision from v3.4.0 to v3.4.1. This appears to be a minor internal update with no visible changes to the study details or navigation.
    Difference
    0.0%
    Check dated 2026-02-06T11:21:24.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI and metadata label updates include glossary toggles (Show glossary / Hide glossary) and revised fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), with older labels replaced (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-23T02:53:13.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 (replacing v3.3.3), a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T23:59:00.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page now includes a Locations section listing Texas as a study site (Houston, TX); the HHS Vulnerability Disclosure link and the Texas Locations header were removed.
    Difference
    0.2%
    Check dated 2025-12-18T03:08:18.000Z thumbnail image

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.